ArticleHaematologica2022

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.

Pierre Allard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.